NCT07770035

Brief Summary

Neonatal HIE increases the risk for cognitive impairments in childhood. Neonatal MRI brain scans are a strong predictor for outcome, however a normal scan has only a 35% sensitivity and 85% specificity for a normal outcome. This may be explained by variability in the brain's development over time in response to the initial insult. This project will aim to develop a neonatal MRI machine learning algorithm that incorporates both initial injury and radiomic features associated with future brain development (based on school-age MRI) to predict school-age outcome. This will be achieved by conducting a case-control cohort study looking at School-age MRI and outcomes of children with a history of neonatal HIE.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
196

participants targeted

Target at P50-P75 for all trials

Timeline
28mo left

Started Mar 2024

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress53%
Mar 2024Dec 2028

Study Start

First participant enrolled

March 9, 2024

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

July 9, 2026

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 18, 2026

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

August 18, 2026

Status Verified

August 1, 2026

Enrollment Period

3.8 years

First QC Date

July 9, 2026

Last Update Submit

August 12, 2026

Conditions

Keywords

HIEneonatal encephalopathyneurodevelopmentcognitive outcomeMRI

Outcome Measures

Primary Outcomes (5)

  • Intelligence Quotient

    Kaufman Brief Intelligence Test Second Edition (KBIT-2) is a brief measure of verbal and nonverbal intelligence used with individuals aged from 4 to 90 years.

    Visit 1 - Approx 1.5 hours, aged 5-12 years old

  • Assessment of Exectuive Function

    Cambridge Neuropsychological Test Automated Battery (CANTAB) will be used to assess the following domains: Visual Memory- Delayed Match to Sample (DMS) Working memory- Spatial Working Memory Task (SWM), Spatial Span Task (SSP), Digit Span Task (DGS) Attention/processing speed- Reaction Time Task (RTI), Rapid Visual Processing Task (RVP), Motor Screening Task (MOT) Inhibitory control- Stop Signal Task (SST)

    Visit 1 - Approx 1.5 hours, aged 5-12 years old

  • Volumetric analysis of MRI brain

    Total and regional brain volumetric analysis

    Visit 2 - 20 minute MRI scan, approximately 2-4 months after Visit 1

  • Connectivity analysis of MRI brain

    Analysis of brain connectivity using diffusion tensor data and fransctional anisotopy imaging.

    Visit 2 - 20 minute MRI scan, approximately 2-4 months after Visit 1

  • MRI Machine Learning Model

    Using MRIs completed at school-age and neonatal data, extract radiomic features and ragions of interest (ROIs) to develop machine learning models to predict school-aged cognitive outcome.

    Visit 2 - 20 minute MRI scan, approximately 2-4 months after Visit 1

Secondary Outcomes (4)

  • Behavioural Profile

    Visit 1 - Approx 1.5 hours, aged 5-12 years old

  • Incidence of additional school supports

    Visit 1 - Approx 1.5 hours, aged 5-12 years old

  • Socioeconomic Background

    Visit 1 - Approx 1.5 hours, aged 5-12 years old

  • Cognitively Stimulating Home Environment

    Visit 1 - Approx 1.5 hours, aged 5-12 years old

Study Arms (2)

Hypoxic Ischaemic Encephalopathy (Case)

Children aged 5-12 years old with HIE meeting study inclusion criteria

Age-Matched Control

Healthy controls aged 5-12 years old, now attending mainstream school, who did not have HIE or were not admitted to the neonatal unit within 12 hours of birth.

Eligibility Criteria

Age5 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Cases: Potential participants will be identified from seven previous studies conducted in Cork University Maternity Hospital (CUMH), between January 2013-December 2019. Over this period, term infants ≥36 weeks considered at significant risk of HIE were recruited prospectively to these studies as soon as possible after delivery. Clinical data, blood biomarkers, MRI and EEG recordings were collected and stored in the INFANT databank using unique study numbers. Controls: Children aged between 4-12 years of age, who are attending general paediatric outpatients' clinics at Cork University Hospital (CUH) will be selected as potential participants for the control group. Controls will be healthy children born at ≥ 36 weeks gestation now attending mainstream school who did not have a diagnosis of HIE at birth. To be eligible, they must not have been admitted to the neonatal unit in the first 12 hours after birth and have had a 5-minute Apgar score of ≥7.

You may qualify if:

  • Known diagnosis of HIE of any grade and enrolled in one of seven studies carried out in CUMH and born between 01 JAN 2013 and 31 DEC 2020
  • Documented parental informed consent for their study data to be used in the future for related research and for them to be contacted again.

You may not qualify if:

  • Lack of parental consent for the original study and no permission to be contacted for future research.
  • Death prior to study initiation
  • Congenital malformation or genetic syndrome
  • Controls:
  • Born at ≥ 36 weeks gestation
  • Attending mainstream primary school without a specific developmental diagnosis
  • Diagnosis of perinatal asphyxia or HIE at birth
  • Admission to the neonatal unit within 12 hours of birth
  • Attending a paediatric clinic for a developmental concern
  • Congenital malformation or genetic syndrome

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University College Cork

Cork, Cork, Ireland

Location

MeSH Terms

Conditions

Hypoxia-Ischemia, Brain

Condition Hierarchy (Ancestors)

Brain IschemiaCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesHypoxia, BrainVascular DiseasesCardiovascular DiseasesHypoxiaSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Brian H Walsh, PhD

    University College Cork

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant Neonatologist

Study Record Dates

First Submitted

July 9, 2026

First Posted

August 18, 2026

Study Start

March 9, 2024

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2028

Last Updated

August 18, 2026

Record last verified: 2026-08

Locations